Previous close | 0.5320 |
Open | 0.5380 |
Bid | 0.5135 x 200 |
Ask | 0.5798 x 100 |
Day's range | 0.5177 - 0.5823 |
52-week range | 0.1300 - 3.3400 |
Volume | |
Avg. volume | 1,021,756 |
Market cap | 36.911M |
Beta (5Y monthly) | 0.29 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Greetings, and welcome to the BrainStorm Cell Therapeutics Third Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder, this call is being recorded. And I would now like to introduce your host for today’s […]
Q3 2023 Brainstorm Cell Therapeutics Inc Earnings Call
Brainstorm Cell Therapeutics Inc. ( NASDAQ:BCLI ) is possibly approaching a major achievement in its business, so we...